- Home
- IAG vs RVTY Comparison
IAG vs RVTY Comparison
Compare IAG & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IAG | RVTY |
|---|---|---|
| Founded | 1990 | 1937 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 11.8B |
| IPO Year | 2002 | 1994 |
Fundamental Metrics
Financial Performance| Metric | IAG | RVTY |
|---|---|---|
| Price | $16.14 | $85.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | $17.75 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 6.9M | 1.0M |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $44.84 | $6.34 |
| Revenue Next Year | $1.33 | $5.10 |
| P/E Ratio | ★ $18.66 | $41.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.35 | $81.36 |
| 52 Week High | $24.87 | $118.30 |
Technical Indicators
Market Signals| Indicator | IAG | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 27.00 | 33.32 |
| Support Level | $12.52 | $83.11 |
| Resistance Level | $17.91 | $94.75 |
| Average True Range (ATR) | 1.07 | 3.02 |
| MACD | -0.78 | -0.39 |
| Stochastic Oscillator | 4.87 | 14.14 |
Price Performance
Historical ComparisonAbout IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.